Literature DB >> 8666985

Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.

M Quik1, J Choremis, J Komourian, R J Lukas, E Puchacz.   

Abstract

The present results demonstrate stable expression of alpha-bungarotoxin (alpha-BGT) binding sites by cells of the GH4C1 rat pituitary clonal line. Wild-type GH4C1 cells do not express alpha-BGT binding sites, nor do they contain detectable mRNA for nicotinic receptor alpha2, alpha3, alpha4, alpha5, alpha7, beta2, or beta3 subunits. However, GH4C1 cells stably transfected with rat nicotinic receptor alpha7 cDNA (alpha7/GH4C1 cells) express the transgene abundantly as mRNA, and northern analysis showed that the message is of teh predicted size. The alpha7/GH4C1 cells also express saturable, high-affinity binding sites for 125I-labeled alpha-BGT, with a KD of 0.4 nM and Bmax of 3.2 fmol/10(6) intact cells. 125I-alpha-BGT binding affinities and pharmacological profiles are not significantly different for sites in membranes prepared either from rat brain or alpha7/GH4C1 cells. Furthermore, KD and Ki values for 125I-alpha-BGT binding sites on intact alpha7/GH4C1 cells are essentially similar to those for hippocampal neurons in culture. Sucrose density gradient analysis showed that the size of the alpha-BGT binding sites expressed in alpha7/GH4C1 cells was similar to that of the native brain alpha-BGT receptor. Chronic exposure of alpha7/GH4C1 cells in culture to nicotine or an elevated extracellular potassium concentration induces changes in the number of alpha-BGT binding sites comparable to those observed in cultured neurons. Collectively, the present results show that the properties of alpha-BGT binding sites in transfected alpha7/GH4C1 cells resemble those for brain nicotinic alpha-BGT receptors. If the heterologously expressed alpha-BGT binding sites in the present study are composed solely of alpha7 subunits, the results could suggest that the rat brain alpha-BGT receptor has a similar homooligomeric structure. Alternatively, if alpha-BGT binding sites exist as heterooligomers of alpha7 plus some other previously identified or novel subunit(s), the data would indicate that the alpha7 subunits play a major role in determining properties of the alpha-BGT receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666985     DOI: 10.1046/j.1471-4159.1996.67010145.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.

Authors:  V J Gee; S Kracun; S T Cooper; A J Gibb; N S Millar
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

2.  The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.

Authors:  Tanguy Araud; Sharon Graw; Ralph Berger; Michael Lee; Estele Neveu; Daniel Bertrand; Sherry Leonard
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

3.  Detection of functional nicotinic receptors blocked by alpha-bungarotoxin on PC12 cells and dependence of their expression on post-translational events.

Authors:  E M Blumenthal; W G Conroy; S J Romano; P D Kassner; D K Berg
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

4.  Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors.

Authors:  Kasper Harpsøe; Helle Hald; Daniel B Timmermann; Marianne L Jensen; Tino Dyhring; Elsebet Ø Nielsen; Dan Peters; Thomas Balle; Michael Gajhede; Jette S Kastrup; Philip K Ahring
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

5.  Expression of a neuronal nicotinic acetylcholine receptor in insect and mammalian host cell systems.

Authors:  E M Aztiria; M C Sogayar; F J Barrantes
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

6.  Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.

Authors:  D L Ridley; A Rogers; S Wonnacott
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  Loperamide: a positive modulator for store-operated calcium channels?

Authors:  J L Harper; Y Shin; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  alpha-bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations.

Authors:  S Rakhilin; R C Drisdel; D Sagher; D S McGehee; Y Vallejo; W N Green
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

9.  Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.

Authors:  Yingxian Xiao; Galya R Abdrakhmanova; Maryna Baydyuk; Susan Hernandez; Kenneth J Kellar
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 10.  RIC-3: a nicotinic acetylcholine receptor chaperone.

Authors:  N S Millar
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.